Trademark: 97473305
Word
NEFSPARRI
Status
Pending
Status Code
730
Status Date
Friday, December 22, 2023
Serial Number
97473305
Mark Type
4000
Filing Date
Thursday, June 23, 2022
Published for Opposition
Tuesday, May 23, 2023

Trademark Owner History
Travere Therapeutics, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis

Trademark Events
Dec 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 22, 2023
Sou Extension 1 Granted
Dec 22, 2023
Sou Extension 1 Filed
Dec 22, 2023
Sou Teas Extension Received
Jul 18, 2023
Noa E-Mailed - Sou Required From Applicant
May 23, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Published For Opposition
May 3, 2023
Notification Of Notice Of Publication E-Mailed
Apr 15, 2023
Approved For Pub - Principal Register
Apr 4, 2023
Assigned To Examiner
Jul 12, 2022
New Application Office Supplied Data Entered
Jun 27, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24